The global automated nucleic acid extraction market size was valued at US$ 3.6 Bn in 2025 and is projected to reach US$ 11.7 ...

Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...

When scientists sliced into a block of Siberian permafrost and pulled out a woolly mammoth nicknamed Yuka, they expected to ...

Acuitas Therapeutics, a leader in lipid nanoparticle (LNP) delivery systems for nucleic acid therapeutics, announced that it ...

Changes in genes have been linked to the development of different diseases for a while. However, it's not exactly clear what ...

A research team at The University of Osaka revealed that the loss of heterochromatin can cause a chain reaction leading to ...

Although the year brought a steady stream of new treatments, tests, and cutting-edge science, experts worry about how ...

Researchers at Utah State University revealed new details about CRISPR immune system defenses, such as Cas12a3 systems, that ...

A nano-sized medicine boosts the anti-cancer immune response and eradicates tumors in mice. Researchers at Washington University School of Medicine in St. Louis, working with colleagues at ...

The investment will expand RNA T&T's operations and allow partners of both companies to leverage combined expertise in RNA-LNP therapeutics.

Advancing RNA therapeutics depends on understanding two critical questions: Where do drug candidates go, and what do they do ...

Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most ...